Asymptomatic Left Bundle Branch Block Predicts New-Onset Congestive Heart Failure and Death From Cardiovascular
Peyman N Azadani1, Ata Soleimanirahbar2, Gregory M Marcus2
1Penn State Hershey Medical Center, PA, USA.
Insights
Left bundle branch block (LBBB) is linked to increased risk of new congestive heart failure (CHF) and cardiovascular death, even without prior heart disease. Early detection and intervention for LBBB may improve outcomes.
Area of Science:
- Cardiology
- Electrocardiography
- Public Health
Background:
- Left bundle branch block (LBBB) is a potential risk factor for cardiovascular morbidity and mortality.
- The association requires further characterization in individuals without pre-existing heart conditions.
Purpose of the Study:
- To assess the association between LBBB and new-onset congestive heart failure (CHF) or cardiovascular death.
- To investigate LBBB as a predictor in a population free of clinical heart disease.
Main Methods:
- The study analyzed 1,688 participants (>55 years) from the community-based SPPARCS cohort.
- ECGs and medical history were collected every 2 years for 6 years.
- LBBB at baseline or year 2 predicted CHF and cardiovascular death at years 4 and 6.
Main Results:
- The prevalence of LBBB at baseline was 2.5% (42 participants).
- LBBB was associated with a significantly higher incidence of new CHF (OR: 2.85, P=0.047) and cardiovascular death (OR: 2.35, P=0.044) after adjusting for confounders.
- These associations persisted even in the absence of clinically detectable heart disease.
Conclusions:
- Asymptomatic LBBB is associated with increased risk of new-onset CHF and cardiovascular mortality.
- Further research is needed to explore diagnostic testing and early treatment strategies for asymptomatic LBBB to reduce cardiovascular events.
Background:
Left bundle branch block (LBBB) has been proposed as a risk factor for cardiovascular morbidity and mortality. We sought to characterize the strength of these associations in a population without preexisting clinical heart disease.
Methods:
The association between LBBB and new-onset congestive heart failure (CHF) or death from cardiovascular diseases was examined in 1,688 participants enrolled in the SPPARCS study who were free of known CHF or previous myocardial infarction. SPPARCS is a community-based cohort study in residents of Sonoma, California that are > 55 years. Medical history and 12-lead ECGs were obtained every 2 years for up to 6 years of follow-up. LBBB at enrollment or year 2 was considered "baseline" and assessed as a predictor of CHF and cardiovascular death ascertained at years 4 and 6.
Results:
The prevalence of LBBB at baseline was 2.5% (n = 42). During 6 years of follow-up, 70 (4.8%) people developed new CHF. Incidence of CHF was higher in patients with LBBB than in participants without LBBB. This association persisted after controlling for potential confounders (odds ratio (OR): 2.85; 95% confidence interval (CI): 1.01 - 8.02; P = 0.047). A higher mortality from cardiovascular diseases was also found in participants with LBBB after adjusting for potential confounders (OR: 2.35, 95%CI: 1.02 - 5.41; P = 0.044).
Conclusions:
LBBB in the absence of a clinically detectable heart disease is associated with new-onset CHF and death from cardiovascular diseases. Further study is warranted to determine if additional diagnostic testing or earlier treatment in patients with asymptomatic LBBB can decrease cardiovascular morbidity or mortality.
More Related Videos
08:21Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Mitral Regurgitation I: Introduction
Heart Failure Drugs: β-Blockers
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
